Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.75
Delayed Data
As of Jun 28
 -0.02 / -0.06%
Today’s Change
29.83
Today|||52-Week Range
37.39
+3.91%
Year-to-Date
Better Days Ahead for the Pharma Sector?
Jun 28 / Zacks.com - Paid Partner Content
Epizyme Progressing Well on Two Lead Pipeline Candidates
Jun 26 / Zacks.com - Paid Partner Content
Stock Market News for June 28, 2017
Jun 28 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonob...
Jun 23 / Zacks.com - Paid Partner Content
Merck's CETP Inhibitor Reduces CV Risk in Phase III Study
Jun 28 / Zacks.com - Paid Partner Content
Biotech Movers: Regeneron Slides Back After Big Gains
Jun 23 / TheStreet.com - Paid Partner Content
AstraZeneca's Faslodex Recommended by CHMP for 1st Line Use
Jun 27 / Zacks.com - Paid Partner Content
Samsung Could Sell More Drugs
Jun 23 / TheStreet.com - Paid Partner Content
Sanofi/Regeneron's Kevzara Gets Marketing Approval in EU
Jun 27 / Zacks.com - Paid Partner Content
15 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer
Jun 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close33.77
Today’s open33.86
Day’s range33.65 - 33.99
Volume14,795,086
Average volume (3 months)22,284,673
Market cap$201.1B
Dividend yield3.79%
Data as of 06/28/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.25%
Earnings growth (next 5 years)+5.75%
Revenue growth (last year)+8.13%
P/E ratio28.4
Price/Sales3.79
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.06-0.07%
MRKMerck-0.38-0.58%
SNYSanofi0.000.00%
ABBVAbbVie+0.53+0.73%
Data as of 06/28/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts